Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting enzymes involved in inflammatory and oncological pathways. Its structure supports high binding affinity to specific protein targets due to the trifluoromethylpyridine group, enhancing metabolic stability and membrane permeability. Also explored in the development of CNS-active agents owing to its ability to cross the blood-brain barrier. Commonly employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates.